
In this video, Dr. Dix, discusses the results of two phase III trials that showed that in children with high-risk Wilms tumor, treatment with vincristine and dactinomycin plus the addition of doxorubicin improved outcomes.

Your AI-Trained Oncology Knowledge Connection!


Published: June 5th 2015 | Updated: